<DOC>
	<DOCNO>NCT00413296</DOCNO>
	<brief_summary>The purpose study evaluate short-term efficacy safety levetiracetam post-traumatic stress disorder ( PTSD ) evaluate continuation effect levetiracetam prevent PTSD relapse . The hypothesis levetiracetam safe effective preventing relapse PTSD .</brief_summary>
	<brief_title>Levetiracetam Post-Traumatic Stress Disorder</brief_title>
	<detailed_description>This investigator-initiated , single site study , consist two phase : 8 week open label treatment levetiracetam ( 500-2000 mg/day ) patient PTSD , demonstrate least minimal improvement , 12 week randomize , double-blind treatment either levetiracetam matching placebo .</detailed_description>
	<mesh_term>Disease</mesh_term>
	<mesh_term>Stress Disorders , Traumatic</mesh_term>
	<mesh_term>Stress Disorders , Post-Traumatic</mesh_term>
	<mesh_term>Etiracetam</mesh_term>
	<mesh_term>Piracetam</mesh_term>
	<criteria>age 1865 primary diagnosis PTSD base DSMIV criterion assess MINI International Neuropsychiatric Interview ( MINI ) Davidson Trauma Scale ( DTS ) score least 40 screen ability provide write informed consent primary DSMIV Axis I disorder PTSD substance abuse last 6 month clinically unstable medical condition clinically significant laboratory abnormality suicide risk serious suicide attempt last year concurrent use psychotropic medication include benzodiazepine , barbiturate , antiepileptic drug , antidepressant , buspirone , dietary supplement herbal homeopathic remedy psychotropic effect recent ( within last 3 month ) initiation cognitive behavioral therapy failure previous trial levetiracetam 2000 mg/day pregnancy lactation woman childbearing potential unwilling practice acceptable method contraception</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>June 2010</verification_date>
	<keyword>PTSD</keyword>
	<keyword>Anxiety</keyword>
	<keyword>Pharmacotherapy</keyword>
	<keyword>Levetiracetam</keyword>
	<keyword>Relapse prevention</keyword>
</DOC>